Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

November 20, 2021

Study Completion Date

December 20, 2021

Conditions

PostmenopauseHot Flashes

Interventions

DRUG

Fluoxetine 20 MG

Participants received non-hormonal treatment with fluoxetine.

DRUG

Citalopram 20mg

Participants received non-hormonal treatment with citalopram.

Trial Locations (1)

Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE, Mexico City

All Listed Sponsors

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

collaborator

National Polytechnic Institute, Mexico

OTHER

lead

Hospital Regional 1o de Octubre

OTHER

NCT05346445 - Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome | Biotech Hunter | Biotech Hunter